首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   202篇
  免费   40篇
  国内免费   5篇
  247篇
  2021年   4篇
  2018年   6篇
  2017年   4篇
  2016年   12篇
  2015年   13篇
  2014年   7篇
  2013年   12篇
  2012年   7篇
  2011年   10篇
  2010年   11篇
  2009年   9篇
  2008年   6篇
  2007年   7篇
  2006年   6篇
  2005年   8篇
  2004年   3篇
  2003年   11篇
  2002年   6篇
  2001年   4篇
  1997年   2篇
  1995年   2篇
  1994年   2篇
  1991年   3篇
  1990年   2篇
  1989年   2篇
  1988年   2篇
  1987年   3篇
  1986年   3篇
  1985年   2篇
  1984年   6篇
  1983年   3篇
  1982年   6篇
  1981年   3篇
  1980年   7篇
  1979年   4篇
  1978年   2篇
  1977年   2篇
  1976年   5篇
  1975年   3篇
  1974年   6篇
  1973年   5篇
  1972年   4篇
  1971年   1篇
  1969年   2篇
  1968年   2篇
  1967年   2篇
  1966年   2篇
  1965年   5篇
  1963年   3篇
  1961年   1篇
排序方式: 共有247条查询结果,搜索用时 0 毫秒
41.
42.
The affinity of ortho-iodinated hexestrols for the estrogen binding protein from rat uterus, determined by competitive binding assay, decreases with progressive iodine substitution; 3-iodohexestrol (I-Hex) has a binding affinity 42% that of estradiol. Analysis of [3-H]-I-Hex binding in rat uterine cytosol by sucrose density gradient centrifugation shows both an estrogen-specific binding component (8 S) and a more abundant component (4 S) that is not estrogen specific. Scatchard analysis indicates that this latter binding is of high affinity (Kd equals to 3.7-8.3 times 10- minus-9 M) but is not uterine specific. Polyacrylamide gel electrophoresis shows that most of the [3-H]-I-Hex binding activity in serum and uterine cytosol is distinct from and anodic to the principal protein component (albumin), and that is comigrates with [14-C]thyroxine binding activity. In in vitro incubation of rat uteri, I-Hex can block the specific uptake of [3-H]estradiol into the nuclear fraction; it itself causes a translocation of estrogen-specific binding capacity (as measured by exchange) from cytoplasm to nuclei, and can induce the synthesis of an estrogen-specific uterine protein, all under conditions where it is not metabolically deiodinated to hexestrol. The uterotrophic activities of the iodohexestrols are in most cases comparable to that expected on the basis of their competitive binding affinities. However, selective, estrogen-specific uptake of [3-H]-I-Hex into rat uterus, either in vitro or in vivo, cannot be demonstrated.  相似文献   
43.
44.
In 1911, the first retrovirus was described: the Rous sarcoma virus, an avian retrovirus. Forty years later the murine leukemic virus, a mouse retrovirus, was reported. Although many other retroviruses from non-primate species were identified during the 1960s, the first primate retrovirus was not recognized until it was isolated from a monkey tumor in 1970. The search for human retroviruses in human leukemic cells remained unsuccessful at that time. Facilitated by the discovery of T-cell growth factor, a substance used for the propagation of human leukocytes in cultures, the first human retrovirus was discovered in 1980. Soon thereafter, in 1983, another human retrovirus, human immunodeficiency virus (HIV), was reported and implicated as the etiologic agent of AIDS. The isolation and identification of HIV has stimulated much interest in the study of human retroviruses and the control of this new viral disease.  相似文献   
45.
46.
SVS I was exclusively expressed in seminal vesicle in which the protein was immunolocalized primarily to the luminal epithelium of mucosal folds. The developmental profile of its mRNA expression was shown to be androgen‐dependent, manifesting a positive correlation with the animal's maturation. There are 43 glutamine and 43 lysine residues in one molecule of SVS I, which is one of the seven major monomer proteins tentatively assigned on reducing SDS–PAGE during the resolution of mouse seminal vesicle secretion. Based on the fact that SVS I‐deduced protein sequence consists of 796 amino acid residues, we produced 7 recombinant polypeptide fragments including residues 1–78/F1, residues 79–259/F2, residues 260–405/F3, residues 406–500/F4, residues 501–650/F5, residues 651–715/F6, and residues 716–796/F7, and measured the covalent incorporation of 5‐(biotinamido)pentylamine (BPNH2) or biotin‐TVQQEL (A25 peptide) to each of F1‐to‐F7 by type 4 transglutaminase (TG4) from the coagulating gland secretion. F2 was active to a greater extent than the other fragments during the BPNH2‐glutamine incorporation, and a relatively low extent of A25‐lysine cross link was observed with all of the seven fragments. The MS analysis of BPNH2‐F2 conjugate identified Q232 and Q254 as the two major TG4 cross‐linking sites. This was substantiated by the result that much less BPNH2 was cross‐linked to any one of the three F2 mutants, including Q232G and Q254G obtained from single‐site mutation, and Q232G/Q254G from double‐site mutation. J. Cell. Biochem. 107: 899–907, 2009. © 2009 Wiley‐Liss, Inc.  相似文献   
47.
48.
49.
Eleven cyclic diarylheptanoids and seven related compounds were screened as potential antitumor promoters by using the in vitro short-term 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced Epstein-Barr virus early antigen (EBV-EA) activation assay. In addition, the cyclic diarylheptanoid myricanone (2) was examined for antitumor initiating activity in a two-stage carcinogenesis assay of mouse skin tumors induced by peroxynitrite as an initiator and TPA as a promoter. Myricanone (2) exhibited significant antitumor-initiating effect on mouse skin. These data suggest that cyclic, as well as linear, diarylheptanoids might be valuable chemopreventors.  相似文献   
50.
荒漠昆虫天花吉丁虫的呼吸及体内水分损失特征   总被引:1,自引:0,他引:1  
为研究荒漠地区昆虫的呼吸及水分损失特征,以专性寄生在荒漠植物梭梭上的天花吉丁虫Julodis variolaris Pallas为对象,采用LI-6400光合分析仪测定在20℃下天花吉丁虫的呼吸量,并采用重量法测定了不同温度下其水分散失率。结果表明:天花吉丁虫呼吸为典型的不连续气体交换循环(discontinuous gas exchange cycle, DGC)的模式,DGC平均周期约需12.96 min,爆发间期历时平均约占整个DGC历时的80%,CO2平均释放率为23.45 μL/min。在25℃、30℃、35℃和40℃恒温条件下,单位时间内水分散失随温度升高而增加,10 h内25℃和30℃之间的水分损失率无显著差异,但25℃和30℃与35℃、40℃之间的水分损失率具有显著性差异;10~24 h内25℃、30℃、35℃之间的水分损失率具有显著性差异。荒漠昆虫天花吉丁虫在高温下的高脱水率和高死亡率说明,其在没有水分来源的情况下很难存活,而不连续呼吸模式是其适应高温干旱环境的对策之一。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号